Stacy L. Taylor, SVP and General Counsel at Adaptive Biotechnologies Corp (ADPT), sold 662 shares at $30.00 ($20K) on 2020-01-08, disclosed to the SEC on 2020-02-18.
Scheduled sale ($20k) by SVP and General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| Filing → |
| ADPT | SELL | 2023-03-08 | $277K | — | Filing → |
| ADPT | SELL | 2022-03-10 | $27K | — | Filing → |
| ADPT | SELL | 2022-03-08 | $19K | — | Filing → |